Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

RNA Expression of Cytochrome P450 in Breast Cancer Patients

RADKA VACLAVIKOVA, MILUSE HUBACKOVA, JANA STRIBRNA-SARMANOVA, ROMAN KODET, MARCELA MRHALOVA, JAN NOVOTNY, IVAN GUT and PAVEL SOUCEK
Anticancer Research November 2007, 27 (6C) 4443-4450;
RADKA VACLAVIKOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rvaclavikova@szu.cz
MILUSE HUBACKOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANA STRIBRNA-SARMANOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROMAN KODET
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCELA MRHALOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN NOVOTNY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IVAN GUT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAVEL SOUCEK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 6C 4443-4450
PubMed 
18214058

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 29, 2007
  • Revision received September 11, 2007
  • Accepted October 10, 2007
  • Published online November 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. RADKA VACLAVIKOVA1,
  2. MILUSE HUBACKOVA1,4,
  3. JANA STRIBRNA-SARMANOVA1,
  4. ROMAN KODET2,
  5. MARCELA MRHALOVA2,
  6. JAN NOVOTNY3,
  7. IVAN GUT1 and
  8. PAVEL SOUCEK1
  1. 1Group for Biotransformations, Center of Occupational Diseases, National Institute of Public Health, 100 42 Prague, Czech Republic
  2. 2Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic
  3. 3Department of Oncology, General Teaching Hospital and 1st Faculty of Medicine, Charles University, 121 08 Prague
  4. 4Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
  1. Correspondence to: Radka Vaclavikova, Ph.D., Group for Biotransformations, Center of Occupational Diseases, National Institute of Public Health, Srobarova 48, 100 42 Praha 10, Czech Republic. Tel: +420267082709, Fax: +420267311236, e-mail: rvaclavikova{at}szu.cz, web: www.szu.cz

Cited By...

  • 24 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6C)
Anticancer Research
Vol. 27, Issue 6C
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
RNA Expression of Cytochrome P450 in Breast Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
RNA Expression of Cytochrome P450 in Breast Cancer Patients
RADKA VACLAVIKOVA, MILUSE HUBACKOVA, JANA STRIBRNA-SARMANOVA, ROMAN KODET, MARCELA MRHALOVA, JAN NOVOTNY, IVAN GUT, PAVEL SOUCEK
Anticancer Research Nov 2007, 27 (6C) 4443-4450;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
RNA Expression of Cytochrome P450 in Breast Cancer Patients
RADKA VACLAVIKOVA, MILUSE HUBACKOVA, JANA STRIBRNA-SARMANOVA, ROMAN KODET, MARCELA MRHALOVA, JAN NOVOTNY, IVAN GUT, PAVEL SOUCEK
Anticancer Research Nov 2007, 27 (6C) 4443-4450;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire